Trademark: VYROLOGIX 2089909
Word
VYROLOGIX
ID
2089909
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
10 February 2020
Registration Date
10 February 2020
Cancellation Date
15 February 2023
Owner(s)
Service
Goods and Services:
Class 5:
Therapeutic preparations, namely, antibodies for use in targeting the C-C chemokine receptor type 5 [CCR5] cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis.
Therapeutic preparations, namely, antibodies for use in targeting the C-C chemokine receptor type 5 [CCR5] cell receptor, for treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis; therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis.